New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

OSLO, Norway, May 4, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication in 'The Journal of Medical Economics' of a novel health economics methodology used to develop the cost-utility model which compared blue light cystoscopy (BLC®) and...